7-130270730-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001869.3(CPA2):āc.326A>Gā(p.Asn109Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,613,778 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_001869.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CPA2 | ENST00000222481.9 | c.326A>G | p.Asn109Ser | missense_variant | Exon 4 of 11 | 1 | NM_001869.3 | ENSP00000222481.4 | ||
CPA2 | ENST00000416698.1 | n.320A>G | non_coding_transcript_exon_variant | Exon 4 of 8 | 5 | ENSP00000395582.1 | ||||
CPA2 | ENST00000480781.5 | n.343A>G | non_coding_transcript_exon_variant | Exon 4 of 5 | 2 | |||||
CPA2 | ENST00000487259.5 | n.341A>G | non_coding_transcript_exon_variant | Exon 4 of 7 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152182Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000239 AC: 6AN: 251432Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135884
GnomAD4 exome AF: 0.0000554 AC: 81AN: 1461596Hom.: 0 Cov.: 30 AF XY: 0.0000564 AC XY: 41AN XY: 727118
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152182Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.326A>G (p.N109S) alteration is located in exon 4 (coding exon 4) of the CPA2 gene. This alteration results from a A to G substitution at nucleotide position 326, causing the asparagine (N) at amino acid position 109 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at